What is the enterprise number of BV Nefromedi?

The enterprise number of BV Nefromedi is BE0736359662.

What is the address of BV Nefromedi?

The registered office of BV Nefromedi is located at Lindelei 17, 2547 Lint.

When was BV Nefromedi founded?

BV Nefromedi was founded on 14 October 2019.

Does BV Nefromedi have a website?

No website is currently known for BV Nefromedi.

How much profit did BV Nefromedi make in 2025?

BV Nefromedi posted a profit after taxes of € 161,625 in financial year 2025.

What is the revenue of BV Nefromedi?

As a small company, BV Nefromedi is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 216,149.

Where can I find the annual accounts of BV Nefromedi?

BV Nefromedi files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.

Who are the directors of BV Nefromedi?

According to the 2025 annual accounts, the directors of BV Nefromedi are: Johan Scharpé.

BV Nefromedi (Private Limited) - Lint (2547) - BE0736359662

Financials

Financial year 2025

Gross margin

€ 216,149

▲ 1% vs 2024

Profit

Healthy

€ 161,625

▼ 17% vs 2024

Debts

Low

€ 94,946

▼ 76% vs 2024

BV Nefromedi from Lint, company number BE0736359662, closed financial year 2025 with a result of € 161,625 after tax. For that financial year BV Nefromedi recorded a gross margin of € 216,149 and equity of € 71,625. Compared with financial year 2024, the result moved from € 195,054 to € 161,625. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What happened at BV Nefromedi?

What happened at BV Nefromedi in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 24, 2026 New annual accounts for financial year 2025: profit of € 161,625 (▼ 17% vs 2024). Source: NBB ↗
Oct 14, 2019 New establishment in Lint. KBO
Oct 14, 2019 Start of the company according to the CBE. KBO
2019 Johan Scharpé became a director. NBB

In short

From € 196,302 profit in 2021 to € 161,625 profit in 2025.

Paid € 261,944 in corporate taxes since 2021.

Best year ever: 2021, with € 196,302 profit.

Paid out € 1.2 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at BV Nefromedi? We notify you, reason included.

Follow BV Nefromedi

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New

Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Johan Scharpé

BV Nefromedi

Behind BV Nefromedi is Johan Scharpé.

See the full network in the app

Directors

According to the 2025 annual accounts

Johan Scharpé

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Lindelei 17

2547 Lint

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0736.359.662
VAT number: BE 0736.359.662
Registered office: Lindelei 17, 2547 Lint
Names & denominations: BV Nefromedi
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 October 2019
Peppol: Active · Active since 24 Nov 2023

View on CBE Public ↗ Annual accounts (NBB) ↗